important, as researchers in the drug delivery space are becoming increasingly attracted to solving real health problems. I have been involved for many years in guiding student and postdoctoral fellows in their attempts to translate drug delivery research into clinically relevant products. We do this by designing solutions that may go from the synthesis of new functional biomaterials to the development of modern drug delivery technologies.
My vision for the next phase of the journal is to attract contributing authors that will result in DDTR being recognized globally as the journal of reference for drug delivery research. Our main focus, then, is quality. We plan to attract high-quality papers by appealing to key leaders in the field, worldwide, and giving particular attention to young leaders who are currently part of the CRS Focus Groups and Local Chapters.
As a translational research journal, our focus, necessarily, should be on subjects where both industry and academia have much to say and share. Therefore, we have created BInspirational Notes,^which are intended to provide an easy-to-read view of relevant concepts, ideas, and products. You will benefit from these notes through an open-access dissemination link available at the CRS and Springer web pages.
To accomplish these goals, we have an outstanding team of editors whose profiles you may find in the DDTR web, and a highly responsive editorial board. I am very thankful to all of them for accepting their respective places on the DDTR team during this next phase of the journal. I would also like to thank Prof. V. Labhasetwar for his leadership in bringing the journal to its current state.
In line with the mission of the journal, our publisher, Springer Nature, offers a unique tool for content sharingSharedIt. This tool allows researchers to share content easily and legally by providing links to view-only, full-text subscription research articles that can be posted anywhere-including on social media platforms, author websites, and in institutional repositories. So researchers can share research with colleagues and general audiences.
In closing, I would like to welcome suggestions and feedback from you, our readers and authors. I am fully engaged with the CRS and committed to making DDTR a leading journal. I am very thankful to the Board of the CRS for nominating me for this position.
